NOT KNOWN DETAILS ABOUT MODAFINIL NORGE

In individuals who are deficient in CYP2D6, coadministration of modafinil with substrates of CYP2D6 that have ancillary routes of elimination by means of CYP2C19 (eg, tricyclic antidepressants and selective serotonin reuptake inhibitors) could cause elevated circulating levels of these medications and call for dose adjustment (Robertson et al 2000;